Sentence examples for uninterrupted therapy from inspiring English sources

The ART status of the patient is recorded as either unsuccessful tracing attempt, death of the patient, transfer to another ART facility, uninterrupted therapy with alternate ART source, never started ART or stop of all prescribed antiretroviral drugs.

Systems that predict the actual time to virologic failure, indicated by a viral load rebound following a cART-induced viral load reduction, or no viral load reduction after a few months of uninterrupted therapy, have not been developed yet.

A higher persistence in therapy was reported for SSRIs versus SNRIs (15.1% versus 13.0%), and escitalopram was associated with the highest percentage of persistent patients and the highest number of days of uninterrupted therapy.

CVVH, continuous veno-venous hemofiltration; CVVHD, continuous veno-venous hemodialysis; CVVHDF, continuous veno-venous hemodiafiltration; KCALC, calculator-estimated urea clearance; KDEL, delivered clearance evaluated from urea concentrations on simultaneous blood and effluent samples; T0, therapy start; T18, 18 to 24 hours of uninterrupted therapy.

CVVH, continuous veno-venous hemofiltration; CVVHD, continuous veno-venous hemodialysis; KCALC, calculator-estimated urea clearance; KDEL, delivered clearance evaluated from urea concentrations on simultaneous blood and effluent samples; T0, at therapy start; T18, after 18 to 24 hours of uninterrupted therapy.

Mean duration of ART among patients with TI(s) was 15±14.9 months (range 0 75 months), which is significantly below the mean for patients with uninterrupted therapy between 2008 and 2009 (mean 25.8±20.4; range 0 125 months; p<0.0001; adjusted for sex and age).

The risk of postpolypectomy bleeding (PPB) in patients undergoing colonoscopy on uninterrupted clopidogrel therapy has not been established.

Uninterrupted warfarin therapy with therapeutic anticoagulation has been shown to be associated with lower risk of periprocedural thromboembolic events after AF ablation and is increasingly being accepted as the preferred anticoagulation strategy [ 82].

Patients with CVIDs can survive for many years with appropriate and uninterrupted IVIG therapy, although they experience higher death rates than the general population even in developed countries [ 36, 37, 41, 43, 44].

They also serve to potentially alleviate some of the concerns raised by the rather unfavourable results in earlier studies (2.1% stroke or TIA and 6.2% major bleeds), 9 suggesting that dabigatran significantly increased the risk of bleeding or thromboembolic complications compared with uninterrupted warfarin therapy.

Given the increased use of drug-eluting stents and the need to maintain uninterrupted dual antiplatelet therapy in these cases, the discontinuation of ticagrelor in the real world may lead to increased stent thrombosis or atherothrombotic events.